These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32483203)

  • 41. Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome.
    Savolainen E; Matinlauri I; Kautiainen H; Luosujärvi R; Kaipiainen-Seppänen O
    Clin Exp Rheumatol; 2008; 26(5):922-5. PubMed ID: 19032830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning.
    Liu J; Chen N
    J Orthop Surg Res; 2021 Jan; 16(1):44. PubMed ID: 33430905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis.
    Cuervo A; Celis R; Julià A; Usategui A; Faré R; Ramírez J; Azuaga AB; Lorenzo A; Sanmartí R; Pablos JL; Cañete JD
    Front Med (Lausanne); 2021; 8():656667. PubMed ID: 33898490
    [No Abstract]   [Full Text] [Related]  

  • 44. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
    Wright HL; Thomas HB; Moots RJ; Edwards SW
    Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness.
    Grcevic D; Jajic Z; Kovacic N; Lukic IK; Velagic V; Grubisic F; Ivcevic S; Marusic A
    J Rheumatol; 2010 Feb; 37(2):246-56. PubMed ID: 20008919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EULAR definition of "arthralgia suspicious for progression to rheumatoid arthritis" in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound.
    Ruta S; Prado ES; Chichande JT; Ruta A; Salvatori F; Magri S; Salinas RG
    Clin Rheumatol; 2020 May; 39(5):1493-1499. PubMed ID: 31933033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging?
    Emad Y; Ragab Y; Shaarawy A; Abou-Zeid A; Saad A; Fawzy M; Jokhdar H; Rasker JJ
    J Rheumatol; 2009 Sep; 36(9):1963-70. PubMed ID: 19648303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity.
    Chen J; Li S; Shi J; Zhang L; Li J; Chen S; Wu C; Shen B
    Rheumatol Int; 2016 Mar; 36(3):359-64. PubMed ID: 26462672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
    Ji L; Li G; Xu Y; Zhou W; Zhang Z
    Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum PGLYRP‑1 is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
    Luo Q; Li X; Zhang L; Yao F; Deng Z; Qing C; Su R; Xu J; Guo Y; Huang Z; Li J
    Mol Med Rep; 2019 Jan; 19(1):589-594. PubMed ID: 30431075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients.
    Teixeira VH; Olaso R; Martin-Magniette ML; Lasbleiz S; Jacq L; Oliveira CR; Hilliquin P; Gut I; Cornelis F; Petit-Teixeira E
    PLoS One; 2009 Aug; 4(8):e6803. PubMed ID: 19710928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
    Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
    J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a multi-biomarker disease activity test for rheumatoid arthritis.
    Centola M; Cavet G; Shen Y; Ramanujan S; Knowlton N; Swan KA; Turner M; Sutton C; Smith DR; Haney DJ; Chernoff D; Hesterberg LK; Carulli JP; Taylor PC; Shadick NA; Weinblatt ME; Curtis JR
    PLoS One; 2013; 8(4):e60635. PubMed ID: 23585841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentially Expressed Genes of Natural Killer Cells Can Distinguish Rheumatoid Arthritis Patients from Healthy Controls.
    Elemam NM; Hachim MY; Hannawi S; Maghazachi AA
    Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32365786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients.
    Chalan P; Bijzet J; van den Berg A; Kluiver J; Kroesen BJ; Boots AM; Brouwer E
    Sci Rep; 2016 May; 6():26021. PubMed ID: 27189045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab.
    de Jong TD; Vosslamber S; Blits M; Wolbink G; Nurmohamed MT; van der Laken CJ; Jansen G; Voskuyl AE; Verweij CL
    Arthritis Res Ther; 2015 Mar; 17(1):78. PubMed ID: 25889713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of
    Gautam S; Kumar U; Kumar M; Kanga U; Dada R
    Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
    [No Abstract]   [Full Text] [Related]  

  • 58. A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory Arthritis.
    Grossi V; Infantino M; Manfredi M; Meacci F; Bellio E; Bellio V; Gobbi FL; Ugolini S; Catani S; Sarzi-Puttini P; Atzeni F; Benucci M
    Curr Rheumatol Rev; 2017; 13(2):93-97. PubMed ID: 27363504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
    Thurlings RM; Boumans M; Tekstra J; van Roon JA; Vos K; van Westing DM; van Baarsen LG; Bos C; Kirou KA; Gerlag DM; Crow MK; Bijlsma JW; Verweij CL; Tak PP
    Arthritis Rheum; 2010 Dec; 62(12):3607-14. PubMed ID: 20722020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of the Progression of Undifferentiated Arthritis to Rheumatoid Arthritis Using DNA Methylation Profiling.
    de la Calle-Fabregat C; Niemantsverdriet E; Cañete JD; Li T; van der Helm-van Mil AHM; Rodríguez-Ubreva J; Ballestar E
    Arthritis Rheumatol; 2021 Dec; 73(12):2229-2239. PubMed ID: 34105306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.